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ABSTRACT The structure and thermal stability of empty
and peptide-filled forms of the murine class II major histo-
compatibility complex (MHC) molecule I-Ek were studied at
neutral and mildly acidic pH. The two forms have distinct
circular dichroic spectra, suggesting that a conformational
change may accompany peptide binding. Thermal stability
profiles indicate that binding of peptide significantly in-
creases the thermal stability of the empty heterodimers at
both neutral and mildly acidic pH. Free energies calculated
from these data provide a direct measure of this stabilization
and show that the empty form of I-Ek is significantly more
stable than that of class I MHC proteins. Furthermore, for the
two MHC class II proteins that were analyzed (I-Ek and I-Ad),
thermal stability was not significantly altered by acidification.
In contrast, of four class I MHCmolecules studied, three have
shown a significant loss in complex stability at low pH. The
marked stability exhibited by their empty form, as well as their
resistance to low pH, as observed in this study, correlate well
with the ability of class IIMHCmolecules to traverse and bind
peptides in acidic endosomal vesicles.
Class I and class II major histocompatibility complex (MHC)
molecules are heterodimeric cell surface glycoproteins that
bind antigenic peptides and display them for surveillance by T
lymphocytes (1). The twoMHC classes have a similar structure
with two membrane-proximal immunoglobulin-like constant
domains and a membrane-distal peptide-binding groove
formed by two a-helices atop an eight-stranded b-sheet floor
(2, 3). The interaction between the MHC molecule and the
peptide not only forms the basis for the heterodimer function
in antigen presentation but also plays a decisive role in its
thermodynamic stability. For class I molecules, the presence of
an appropriate peptide has been shown, in most circumstances,
to be imperative for successful folding and surface expression
at physiological temperature (1, 4–8). The free energy con-
tributed by peptide binding to empty class I Kd heterodimers
has been determined (9) and the binding energies contributed
by peptide contacts at anchor positions (10–13) and at the
peptide NH2 and COOH termini (8) have been reported for
several alleles. The stability of class II molecules also depends
on the peptide (1, 14), though apparently to a lesser extent than
class I molecules (15). In addition, the binding of peptides to
class II proteins is pH-dependent. For most class II alleles,
peptide binding is enhanced at low pH (1, 16–20), consistent
with the pH of the endosomal-like compartment (pH '5.0)
where peptide loading takes place. At that pH, it has been
suggested that the molecules adopt an alternate ‘‘open’’ con-
formation that facilitates peptide binding (21–24) and that has
been proposed to be less stable than the form adopted at
neutral pH (21, 23–25).
In spite of these observations, direct quantitative data
regarding the energetic consequences of peptide binding or
alteration in the pH on the stability of class II proteins has not
been reported. Herein, we compare the thermal denaturation
profiles exhibited by the murine class II protein I-Ek in the
presence or absence of a specific peptide, moth cytochrome c.
From these data, the free energy of the empty state, as well as
that contributed by moth cytochrome c to the stabilization of
the heterodimer, are derived. In addition, the thermal stability
of two class II heterodimers, I-Ek and I-Ad, is analyzed at
neutral and mildly acidic pH. To assess whether the differences
in biosynthesis and localization of antigen binding between
class I and class II proteins might be reflected in their
resistance to low pH, the effect of the pH on the thermal
stability of four class I proteins at the relevant pH range has
also been studied.
EXPERIMENTAL PROCEDURES
Soluble Proteins. Empty I-Ek heterodimers were expressed
as glycosylphosphatidylinositol-anchored chimera in Chinese
hamster ovary cells and were digested from the cell surface and
purified as described (18, 19). Apparently, these GPI-linked
chimeras do not traffic through the cell’s endosomal compart-
ments and consequently lack bound peptides as evidenced by
labeled peptide binding experiments (19), by the fact that no
peptides can be eluted from the molecules (H. Schild, P. A.
Reay, and M.M.D., unpublished results), by the observation
that the I-Ek bearing cells were unable to present endogenously
processed peptides to a specific T-cell line (18), and by their
distinct unfolding behavior and stability as described herein.
I-Ek molecules complexed with moth cytochrome c (residues
88–103) peptide were prepared and purified as reported (26,
27). Soluble I-Ad (mouse) with Ea peptide (residues 52–68)
covalently linked to the heterodimer b chain was constructed
by exchanging the peptide portion of I-AdyOVA cDNA (28) by
that of the Ea sequence obtained from an I-AbyEa construct
(29). Baculovirus containing the I-AdyEa sequence was used
to infect High Five insect cells (Invitrogen) as described (30)
and the recombinant protein was immunoaffinity purified with
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the monoclonal antibody M5y114. Secreted forms of the
following class I MHC molecules were obtained by following
the procedures as outlined (9, 31): HLA-A2 [human, com-
plexed with HIV pol (RT) peptide, residues 309–317], HLA-
B27 (human, complexed with an endogenous mixture of
CHO-derived peptides), H-2Kd [(mouse, complexed with hu-
man b2-microglobulin, b2m), complexed with a myeloma
(MOPC21)-derived IgHV peptide, residues 49–58)], and
HLA-B35 (human, complexed with HIV nef peptide, residues
73–82).
Circular Dichroism (CD) and Thermal Denaturation Stud-
ies. CD spectra were recorded in a 0.1-cm path-length cell on
an AVIV 62A DS spectropolarimeter (Aviv Associates, Lake-
wood, NJ) equipped with a thermoelectric cell holder, using a
step size of 0.25 nm, a bandwidth of 1 nm, and a time constant
of 1 sec. Protein solutions were made in 5 mM sodium
phosphatey5 mM sodium acetate buffer and were brought to
the indicated pH with concentrated stocks of HCl or NaOH.
Spectra shown in the text represent the average of three
measurements, each representing the average of five repetitive
scans, and were smoothed by using a sliding window of nine
(2.25 nm). Far-UV data are given as [u]r, the mean residue
ellipticity, and the near-UV data are expressed as molar
ellipticity, [u]. Thermal denaturation curves of the various
MHC proteins were obtained by following the CD signal at 222
(class II) or 223 (class I) nm as a function of the temperature
in a 1-cm path-length cell. The temperature was increased in
a step-wise mode (2–2.58C intervals) with each temperature
jump being followed by a 100-sec equilibration time. Record-
ing time was 50 sec. Each point in the melting curves shown in
the text represents the average of three experiments. Revers-
ibility of the thermal unfolding was demonstrated by using
standard heatingycooling cycles in which samples were initially
scanned at 258C, heated to temperatures well above the
midpoint temperature of the thermal unfolding transition Tm
of the protein complex analyzed, immediately cooled back to
258C, and scanned after an equilibration period of 1 h. The CD
spectra at high temperatures were recorded separately to avoid
the formation of kinetically driven irreversibly unfolded spe-
cies due to long incubation times at high temperatures.
Free Energy Calculations. Thermodynamic parameters
were derived from the CD data presented in the text, assuming
a two-state unfolding model. Derivation of the free energy
change DG at physiological temperature (378C), which lies
below the transition region of the unfolding curves where the
equilibrium constant K cannot be directly derived, was made
by using the following form of the Gibbs–Helmholtz equation:
DG(T) 5 DHm(1 2 TyTm) 2 DCp[(Tm 2 T) 1 T ln(TyTm)],
where T is the Kelvin temperature, Tm is the midpoint tem-
perature of the thermal unfolding transition, DHm is the
enthalpy change for unfolding measured at Tm, and DCp is the
difference in heat capacity between the folded and unfolded
conformations. Tm andDHmwere obtained from the van’t Hoff
equation: DH 5 RT2(dln K)y(dT), in which R is the gas
constant. DCp values were assumed to be independent of
temperature (32) and were estimated from: DCp 5 (dDH)y
(dT)p. Values of K(T) inside the transition region of the
unfolding curves were derived, after sloping corrections, from
the following relation:K(T)5 (uN2 uT)y(uT2 uU), where (uN)
and (uU) are the limiting ellipticity values representing the
native and unfolded states, respectively, and (uT) is the ob-
served ellipticity at T.
RESULTS AND DISCUSSION
The far-UV CD spectra of empty and peptide-filled I-Ek
molecules at different temperatures and pHs are shown in Fig.
1A. At neutral pH and at 258C, the spectra are very similar to
each other and are consistent, as expected, with proteins
containing a substantial amount of b-sheet and a considerable
portion of a-helical structure (33). An increase in the tem-
perature to 378C, however, results in some loss of the CD signal
exhibited by the empty but not by the peptide-filled molecules.
Decreasing the pH to 5.0 has a similar effect on the CD
spectrum of empty I-Ek but this time a slight decrease can also
be observed in the spectrum exhibited by the peptide-filled
heterodimers. The preferential decrease in the CD signal at the
right side of the absorption band is consistent with a slight loss
in helicity (33), suggesting that the lack of peptide and low pH
are accompanied by limited melting in one or both of the
a-helices that form the peptide-binding groove of the mole-
cule. CD analysis in the near-UV range, and at 258C, shows
more pronounced differences between the two forms (Fig. 1B).
Thus, these differences in the CD spectrum of the two forms
suggest that the binding of peptide may be accompanied by a
conformational change in the empty molecules. Changes ob-
served in the near-UV spectra upon protonation may also
reflect pH-induced structural rearrangements but can also be
due to alterations in the polarity of the asymmetric environ-
ment around particular aromatic residues. As discussed below,
for either form, changes in conformation induced by low pH
should be of a fairly localized nature as they are not associated
with a significant change in the free energy of the molecules.
The thermal melting profiles of empty and peptide-bound
I-Ek at neutral and mildly acidic pH are shown in Fig. 2A and
the values for the midpoint of the thermal unfolding transitions
Tm are summarized in Table 1. As shown (Fig. 2 C and D), at
either pH, the thermal transitions of the two forms are largely
reversible. At neutral pH, a sharp single transition with a Tm
at 708C is observed for the peptide-bound molecules. The
presence of only a single transition suggests that chain disso-
ciation and unfolding of the individual chains are coupled. In
contrast, two comparatively broad transitions are evident for
the empty heterodimers. The first is observed at low temper-
atures and may correlate with the limited loss in secondary
structure observed for this form, going from 258 to 378C (Fig.
1A). The second main transition is characterized by a Tm of
628C. The pronounced broadening (low cooperativity) of the
denaturation curve of empty I-Ek indicates that, compared
with the peptide-bound conformation, this form is lacking in
FIG. 1. Far-UV (A) and near-UV (B) CD spectra of empty and
peptide-loaded I-Ek heterodimers at neutral and mildly acidic pH.
Protein concentrations were 0.3 mgyml (A) and 1.5 mgyml (B).
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the strength andyor number of intramolecular contacts, giving
rise to a DHm value as low as 45 kcalymol (1 cal 5 4.184 J).
Structurally, such a low enthalpy of denaturation would be
consistent with a ‘‘loose’’ or an extended conformation, an
observation supported by hydrodynamic measurements (un-
published data). This loose structure could be similar to the
‘‘f loppy’’ form observed during denaturation (21) and folding
(34) of class II molecules and may also explain the tendency of
these proteins to aggregate in the absence of peptide (14, 15).
The relatively high Tm observed for this form, the far-UV CD
data presented above, and the observation that empty class II
molecules are recognized by conformational-sensitive antibod-
ies (15) suggest, however, that the empty state still retains a
high degree of the structure present in the peptide-filled
conformation.
With a Tm at 628C, the empty form of I-Ek is substantially
more stable than most class I molecules lacking peptides.
Empty class I molecules usually fail to assemble at physiolog-
ical temperature (1, 4–8) and, therefore, are likely to have Tm
values lower than 378C. Even when compared with empty
H-2Kd heterodimers, which do assemble at physiological tem-
perature (9), the empty form of I-Ek is still significantly more
stable, with a Tm 178C higher than that determined for that
form of H-2Kd (Table 1).
To estimate the difference in conformational stability be-
tween the two forms of I-Ek, the CD melting curves of the two
species (Fig. 2) were subjected to a thermodynamic analysis in
which a two-state unfolding model was assumed. At physio-
logical temperature and at neutral pH, we calculate changes in
free energy of 2.7 and 6.1 kcalymol for empty and peptide-
filled I-Ek, respectively. Peptide binding thus confers an ad-
ditional stability of 3.4 kcalymol upon empty I-Ek het-
erodimers. This value is comparable, though somewhat lower
than those calculated for the binding of specific peptides to
class I Kd [4.2 kcalymol (9)] and HLA-A2 [.5.8 kcalymol (8)]
molecules. The thermal stability we observe for empty I-Ek,
though relatively low, is significant. At 378C, more than 98%
of the empty heterodimers would be expected to be folded on
the basis of the equilibrium constant derived at this temper-
FIG. 2. Thermal denaturation of empty and peptide-loaded I-Ek heterodimers monitored by CD at pH 7.0 (A) and pH 5.0 (B). Protein
concentrations were 40–60 mgyml. (C and D) Far-UV CD scans of native, unfolded, and renatured empty (C) and peptide-filled (D) I-Ek at neutral
and mildly acidic pH.
Table 1. Thermal stability of class I and class II MHC molecules
at neutral and mildly acidic pH
Molecule Peptide pH Tm, 8C
I-Ek — 7.0 62 6 1
I-Ek ANERADLIAYLKQATK 7.0 70 6 1
I-Ek — 5.0 63 6 1
I-Ek ANERADLIAYLKQATK 5.0 68 6 1
I-Ad ASFEAQGALANIAVDKA 7.0 62 6 1
I-Ad ASFEAQGALANIAVDKA 5.0 61 6 1
HLA-A2 ILKEQVHGV 7.0 59 6 1
HLA-A2 ILKEQVHGV 5.5 45 6 1
HLA-B27 Mixed 7.0 66 6 1
HLA-B27 Mixed 7.0† 63 6 2
HLA-B27 Mixed 5.0† 52 6 2
Kd* — 7.0 45 6 1
Kd* TYQRTRALV 7.0 57 6 1
Kd AYISSGSSTL 7.0 54 6 1
Kd AYISSGSSTL 6.0 54 6 1
Kd AYISSGSSTL 5.5 54 6 1
*From ref. 9.
†Measured in the presence of 300 mM urea.
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ature. Moreover, this surprisingly high thermal stability of
empty I-Ek may not be limited to I-E molecules. HLA-DR1
(human) heterodimers readily assemble in the absence of
antigenic peptide and remain as such throughout a week-long
incubation at 378C (15).
The thermal denaturation curves of empty and peptide-
bound I-Ek at pH 5.0 are shown in Fig. 2B and the results are
summarized in Table 1. Notably, these data show that proto-
nation does not significantly affect the stability of either form
of I-Ek. For both empty and peptide-filled I-Ek, we findmelting
temperature (638 and 688C) and free energies (3.0 and 5.7
kcalymol) that closely match those obtained at neutral pH. To
assess whether the stability of I-Ek at low pH is unique to I-E
molecules, we have also analyzed the thermal stability of
another murine class II molecule, I-Ad, covalently linked to an
Ea peptide (28–30). Consistent with previous observations
(22, 24, 28), I-Ad is less stable than I-Ek as indicated by its lower
transition midpoints at both pH 7.0 and 5.0 (Fig. 3 and Table
1). However, the melting profiles exhibited by the complex at
neutral and mildly acidic pH deviate by only 18C from each
other and are virtually identical in appearance, thus indicating
a similar degree of stabilization.
The results presented above contrast with previous studies
that suggested that protonation of class II proteins is associated
with a substantial loss in complex stability as determined by
their sensitivity to SDS-induced chain dissociation during SDSy
PAGE (21, 23–25). However, the significance of these assays
is not clear. First, some of these studies (21, 25) involved pH
levels (pH#4.5) well below those required for optimal peptide
binding and may have triggered acid-derived denaturation of
the proteins (35). In addition, the binding of SDS to class II
molecules might be pH-dependent. Several studies have sug-
gested that protonation of class II proteins may lead to an
‘‘opening up’’ of the protein structure resulting in an increase
in the solvent accessibility of the molecules (21–24). Although
the results presented herein and elsewhere (23, 36) indicate
that such changes in the structure should be subtle, it is possible
that under these conditions more SDS molecules can bind to
the proteins, thus giving rise to their apparent SDS instability
at low pH. Finally, a recent structural analysis of two I-Eky
peptide complexes has shown that the increase in peptide
binding to class II molecules at low pH could be explained by
small localized changes in theMHC structure that may actually
stabilize the binary complex. Specifically, it was shown that the
P6 pocket in I-E and DR class II molecules contains two acidic
residues (Glua11 and Aspa66) facing each other, whose proto-
nation could be responsible for the observed enhancement in
peptide binding to these molecules at low pH (37).
As opposed to the results observed herein for class II
molecules, a significant number of class I proteins become less
stable at low pH. In particular, it has been shown that the
dissociation rate of the b2m subunit of the class I protein,
HLA-B7, increases by almost an order of magnitude going
from pH 8.0 to 6.0 (38). Similarly, peptide binding studies
conducted on three different class I molecules showed that
protonation was accompanied by a decrease in complex sta-
bility (39). Herein, we have analyzed the effect of the pH on
the thermal stability of four class I molecules. Shown in Fig. 4
are the results obtained for one of these molecules, HLA-A2,
complexed with the HIV pol (RT) peptide. At neutral pH,
HLA-A2 unfolds through a single transition with a Tm at 598C.
The lack of a clear transition of the b2m subunit (Fig. 4B)
strongly suggests that peptide dissociation and unfolding of the
protein heavy and b2m chains have all occurred simultaneously
(8, 9). We next determined the stability of HLA-A2 at mildly
acidic pH (pH 5.5). At that pH, the HLA-A2 heavy chain
unfolds with a Tm at 458C, 148C lower than that measured at
neutral pH. Also note that, under these conditions, a second
transition that closely matches the melting profile of free b2m
is also present, indicating that the two protein chains unfold in
a relatively independent manner. Similar profiles and low Tm
values have been observed before for HLA-A2 molecules
complexed with peptides whose NH2 or COOH terminus was
FIG. 3. Thermal denaturation of peptide-loaded I-Ad het-
erodimers (50 mgyml) monitored by CD. The points shown at 258C
were taken from the full CD spectrum of the renatured protein.
FIG. 4. Thermal denaturation of peptide-loaded HLA-A2 het-
erodimers (50 mgyml) (A) and free b2m (50 mgyml) (B) monitored by
CD. The curve for free b2m was factored by 0.25 to represent its
relative contribution to the mean residue ellipticity of the heterodimer.
The points shown at 258C were taken from the full CD spectrum of the
renatured protein.
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substituted by methyl groups (8) and for empty H-2Kd het-
erodimers (9). These data suggest then that the apparent
instability of HLA-A2 at low pH originates from a pH-induced
peptide-dissociation concomitant with chain separation and
denaturation.
Three additional class I molecules were also analyzed. The
first, HLA-B27, unfolded at neutral pH through a single
transition with a Tm at 668C (Table 1). Initial attempts to
unfold this molecule at mildly acidic pH (5.0–5.8) resulted in
poorly reversible transitions due to aggregation of the protein
sample during the thermal cycles. To overcome this problem,
melting was performed in the presence of subcritical concen-
trations (0.3 M) of urea, a chaotrope. At neutral pH, this
resulted in only a minor reduction in the thermal stability of
the protein, lowering the Tm by only 38C (to 638C, Table 1). At
pH 5.0, however, the Tm decreased to 528C, a degree of
destabilization similar to that observed for HLA-A2. Similar
problems were also encountered when another class I mole-
cule, HLA-B35, was analyzed. In this case, however, complete
melting profiles could not be obtained at low pH, even when
urea concentrations as high as 0.75 M were used. However,
within the range of pH 5.0–5.8, the partial melting curves
observed showed a consistent and progressive shift toward
lower temperatures compared with those obtained at neutral
pH, suggesting that acidification was accompanied by a loss of
thermal stability. Interestingly, the murine class I heavy chain
H-2Kd complexed with human b2m subunit, was the only class
I molecule not destabilized by low pH (Table 1). As mentioned
above, this form of H-2Kd is unusual among class I MHCs in
that its empty state exhibits an exceptionally high thermal
stability.
Physiologically, the differences in stability between the two
MHC classes correlate well with their roles in the antigen-
presenting cell. Class I MHC molecules assemble and bind
peptides inside the endoplasmic reticulum (ER), a situation
that allows these two events to be coupled and that provides
a means for regulating the peptides to be presented; het-
erodimers that fail to bind the right peptides are likely to
unfold and, subsequently, be discarded. This is consistent with
a molecule that is heavily dependent on peptide binding for
being properly folded and assembled. In contrast, for class II
molecules, coupling protein folding and peptide binding would
be mechanistically not feasible since these two processes take
place in different cellular compartments, the ER and the
endosome, respectively. This, in turn, would necessitate a
structure that is relatively independent of peptide for its
assembly (1). In this regard, while the invariant chain protein
is present and associates with class II MHCs in the ER, it is not
required for the folding and assembly of most class II alleles (1,
15), although it may act to keep the nascent molecules in a
disaggregated form, ensuring a proper trafficking of the pro-
teins (14, 15).
Similarly, the ability of class II molecules to maintain their
stability in a low pH environment is also expected. Otherwise,
they would be subjected to a pH-induced unfolding and
subsequent proteolytic degradation inside the acidic endo-
somes in which they reside for several hours (40). The price
paid for such a pH resistance is that once bound, some peptides
are slow to exchange from class II proteins even at low pH. This
includes the class II invariant chain-derived peptide (CLIP)
that occupies the molecules’ binding site upon their entrance
to the endosomal site (41). Indeed, in vitro, class II–CLIP
complexes can be efficiently loaded with antigenic peptides at
low pH only in the presence of some detergents (42, 43), and
the half-life measured for CLIP bound toHLA-DR3molecules
(at pH 4.5 and 378C) is significantly longer than that required
for class II molecules to mature inside the endosome (44). In
vivo, this problem is solved by the action ofMHC-like catalysts,
such as HLA-DM, that promote the release of the bound CLIP
and, thus, allow for a timely exchange by high-affinity peptides
(45, 46).
While the rationale behind the apparent resistance of class
II molecules to low pH is clear, the significance, if any, of the
apparent sensitivity of most class I molecules to low pH is less
obvious. One possibility is that this might be important in
preventing internalized class I molecules (47) from binding
endocytosed ‘‘class II-restricted’’ peptides during recycling
through acidic compartments. This, in turn, would act to
increase segregation of the two presentation pathways. How-
ever, as pointed out above, some variation in pH resistance
exist within this MHC class.
The difference in stability between empty class I and class
II molecules may also affect the peptide repertoire available
for the two MHC classes. Because they have an inherently
higher thermal stability, empty class II molecules would be
expected to bind and present low-affinity peptides better than
class I molecules, in which case complexes are likely to have a
half-life that is too short to be physiologically significant. An
extended peptide repertoire for class II molecules has been
noted (25) and is consistent with observations suggesting a
larger set of protein determinants for class II compared with
class I-restricted T lymphocytes (48).
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